SCHEDULE 13G 0001903793 XXXXXXXX LIVE Class A Common Stock, par value $0.0001 12/31/2025 0001784570 BETA Technologies, Inc. 086921103 1150 Airport Drive South Burlington VT 05403 Rule 13d-1(d) TPG GP A, LLC DE 0.00 16395435.00 0.00 16395435.00 16395435.00 N 7.4 OO The percentage beneficial ownership in Row 11 above is based on a total of 220,528,649 shares of Class A Common Stock (as defined below) outstanding as of December 1, 2025, as reported on the Issuer's (as defined below) Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "Commission") on December 4, 2025. COULTER, JAMES G X1 0.00 16395435.00 0.00 16395435.00 16395435.00 N 7.4 IN The percentage beneficial ownership in Row 11 above is based on a total of 220,528,649 shares of Class A Common Stock outstanding as of December 1, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q filed with the Commission on December 4, 2025. WINKELRIED JON X1 0.00 16395435.00 0.00 16395435.00 16395435.00 N 7.4 IN The percentage beneficial ownership in Row 11 above is based on a total of 220,528,649 shares of Class A Common Stock outstanding as of December 1, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q filed with the Commission on December 4, 2025. BETA Technologies, Inc. 1150 Airport Drive, South Burlington, VT 05403 This Schedule 13G is being filed jointly by TPG GP A, LLC, a Delaware limited liability company ("TPG GP A"), James G. Coulter and Jon Winkelried (each, a "Reporting Person" and, together, the "Reporting Persons"), pursuant to an Agreement of Joint Filing incorporated by reference herein in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). TPG GP A exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., a Delaware corporation, which is the sole member of TPG GPCo, LLC, a Delaware limited liability company, which is the sole member of TPG Holdings II-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group II, L.P., a Delaware limited partnership, which is the sole member of TPG Holdings I-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group I, L.P., a Delaware limited partnership, which is the sole member of TPG Rise Climate GenPar Advisors, LLC, a Delaware limited liability company, which is the general partner of TPG Rise Climate GenPar, L.P., a Delaware limited partnership, which is the sole member of TPG Rise Climate SPV GP, LLC, a Delaware limited liability company, which is the general partner of TPG Rise Belfry, L.P., a Delaware limited partnership ("TPG Rise Belfry"), which directly holds 16,395,435 shares of Class A Common Stock ("Class A Common Stock") of BETA Technologies, Inc. (the "Issuer"). Because of the relationship of TPG GP A to TPG Rise Belfry, TPG GP A may be deemed to beneficially own the shares of Class A Common Stock held by TPG Rise Belfry. TPG GP A is controlled by entities owned by Messrs. Coulter and Winkelried. Because of the relationship of Messrs. Coulter and Winkelried to TPG GP A, each of Messrs. Coulter and Winkelried may be deemed to beneficially own the shares of Class A Common Stock held by TPG Rise Belfry. Messrs. Coulter and Winkelried disclaim beneficial ownership of the securities held by TPG Rise Belfry except to the extent of their pecuniary interest therein. The principal business address of each of the Reporting Persons is as follows: c/o TPG Inc. 301 Commerce Street, Suite 3300 Fort Worth, Texas 76102 See response to Item 4 of each of the cover pages. Y See responses to Item 9 on each cover page. See responses to Item 11 on each cover page. See responses to Item 5 on each cover page. See responses to Item 6 on each cover page. See responses to Item 7 on each cover page. See responses to Item 8 on each cover page. Y Y N See response to Item 2(a) above. Y Y Y Exhibit 1 - Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* _______________ * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc. TPG GP A, LLC /s/ Martin Davidson 02/13/2026 COULTER, JAMES G /s/ Gerald Neugebauer 02/13/2026 WINKELRIED JON /s/ Gerald Neugebauer 02/13/2026 (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).